Skip to content

Clinical trials

Enrolling by invitation Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Status: Enrolling by invitation Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20182
20211
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tsinghua Chang Gung Hospital1
Fudan University1
Gene Solutions1
National Cancer Center, Korea1
National Cancer Institute (NCI)1
Prof. Valérie Mc Lin1
The Methodist Hospital Research Institute1
University of Molise1
University of Pittsburgh1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms10
Carcinoma, Hepatocellular3
Colonic Neoplasms2
Fibrosis2
Lung Neoplasms2
Breast Neoplasms1
Congenital Portosystemic Shunt1
Gastrointestinal Neoplasms1
Hematologic Neoplasms1
Hepatic Encephalopathy1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.